Patients hospitalized with CAP who had an LRTS taken on admission exhibited reduced risk of mortality and were more likely to receive appropriate antibiotic therapy.
Immunocompromised patients with severe community-acquired pneumonia have an increased risk of in-hospital and long-term mortality.
and their efficacy and safety in the management of community-acquired pneumonia (CAP). Data show that CAP is a common presentation in primary care practice, and is associated with high rates of ...
safety and tolerability of oral moxifloxacin in outpatients with respiratory tract infections treated in general practices in Germany with the focus on community-acquired pneumonia (CAP).
1don MSN
We recently published a list of the 12 Best Up and Coming Stocks to Buy According to Wall Street Analysts. In this article, ...
Side effects may occur, which you should report to your healthcare provider. MedlinePlus. Viral pneumonia. Ramirez JA. Overview of community-acquired pneumonia in adults. UpToDate. 2025. Bowerman TJ, ...
Bacterial pneumonia is most commonly caused by a bacteria called Streptococcus pneumoniae which accounts for around 50% of cases. Other common causes include Haemophilus influenzae, Chlamydia ...
Studies confirm a significant link between poor oral health and the risk of developing community acquired pneumonia and demonstrate that implementation of oral care protocols on wards can reduce the ...
ouh.nhs.uk The British Thoracic Society (BTS) guidelines for the management of community-acquired pneumonia in children are used as the audit standard for the annual BTS Paediatric Pneumonia Audit.
Raven Ridge Wildlife Center in Lancaster County provided an update on the beaver that was found underweight and suffering from pneumonia in January. The beaver ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...
1d
Zacks Investment Research on MSNMerck Gets EC Nod for 21-Valent Pneumococcal Jab CapvaxiveMerck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results